AQR Arbitrage LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 42 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
AQR Arbitrage LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$5,089,000
+32.6%
5,750,000
+21.1%
0.23%
+76.6%
Q1 2020$3,838,000
+5.4%
4,750,000
+18.8%
0.13%
+109.8%
Q4 2019$3,641,0004,000,0000.06%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 90,815,000$90,802,6815.68%
PIPER SANDLER & CO. 6,695,000$6,694,0634.58%
Opti Capital Management, LP 46,902,000$46,902,0003.79%
Monashee Investment Management LLC 9,000,000$8,975,1602.48%
TENOR CAPITAL MANAGEMENT Co., L.P. 96,994,000$97,297,0841.93%
DeepCurrents Investment Group LLC 41,092,000$40,966,1771.60%
Sonora Investment Management Group, LLC 9,395,000$9,387,5820.82%
Penn Mutual Asset Management 675,000$677,0180.64%
OAKTREE CAPITAL MANAGEMENT LP 19,540,000$19,586,1990.22%
BRAIDWELL LP 6,500,000$6,515,3680.22%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders